Huron Capital Sells Labstat Stake

Lower mid-market firm Huron Capital has sold its interest in Labstat through its holding company (Apex Laboratories), generating a return in excess of 6 times invested capital. Based in Kitchener, Ontario, Labstat is an independent laboratory system focused on testing for chemical emissions and the biological impact of tobacco smoke.

PRESS RELEASE

Some things look pretty cool when you put them under a microscope. Huron’s investment in Labstat International was one of those things.
Huron recently sold its interest in Labstat through its holding company (Apex Laboratories), generating returns in excess of 6 times invested capital. Based in Kitchener, Ontario, Labstat is the leading independent laboratory system focused on testing for chemical emissions and the biological impact of tobacco smoke. The closer we looked at Labstat’s business and the testing industry, the more we liked it.
This investment definitely passed the test.
About Huron Capital Partners LLC
Huron Capital is one of the leading operationally-focused private equity firms investing in lower middle-market companies. The firm invests up to $70 million to sponsor buyouts, growth initiatives, corporate spin-offs, and recapitalizations of niche manufacturing, specialty service, and value-added distribution companies having revenues up to $300 million. Huron seeks opportunities where it can help companies reach their full potential by combining its operational approach, capital, and transaction experience with proven operating executives who have the vision, experience, and commitment to grow their businesses.
Founded in 1999, Huron has acquired or invested in 58 companies with aggregate revenues in excess of $1 billion. Investments have been made in the USA and Canada in a variety of areas, including document management, education, healthcare products & services, specialty chemicals, specialty packaging, consumer products & apparel, home decor, engineering services, food & beverages, office furniture components, and laboratory testing. Huron Capital has raised over $600 million in committed equity through three private equity funds, and has offices based in Detroit and Toronto. The firm has consistently generated top-quartile returns for its limited partners.